Company Filing History:
Years Active: 2007
Title: Michael F. Addo: Innovator in Guinea Pig Protein Research
Introduction
Michael F. Addo, an accomplished inventor based in Lansdale, Pennsylvania, has made significant contributions to the field of biomedical research. His innovative work has led to the development of a notable patent that focuses on understanding and modeling human platelet aggregation through guinea pig proteins.
Latest Patents
Among his innovative contributions, Michael F. Addo holds a patent for "Guinea pig proteinase-activated receptor 4 and its activating peptide." This invention encompasses the nucleic acid that encodes guinea pig PAR 4 and the corresponding protein it produces. The patent indicates the utility of guinea pig DNA and protein in advancing medical research by aiding in the creation of models for human platelet aggregation. Furthermore, it introduces an animal model designed to evaluate the effects of PAR antagonists in the context of thrombosis.
Career Highlights
Michael F. Addo has established himself as a vital figure in pharmaceutical research while working with Ortho-McNeil Pharmaceutical Corporation. His role within the company has allowed him to play a significant part in the innovation of therapeutic solutions, particularly in the study of platelet functions and related disorders.
Collaborations
Throughout his career, Michael has collaborated with talented individuals, including Andrew Lawrence Darrow and Claudia K. Derian. These collaborations have enabled the advancement of their shared research interests and have contributed to the success of their projects within the pharmaceutical sector.
Conclusion
In conclusion, Michael F. Addo's dedication to his work and innovative contributions in the realm of protein research underscore his status as a noteworthy inventor in the medical field. His patented work not only aims to enhance our understanding of human health but also offers avenues for further research and development in effective treatments for conditions related to platelet aggregation.